As of 2025-07-05, the Relative Valuation of Iovance Biotherapeutics Inc (IOVA) is (15.40) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.75 USD, the upside of Iovance Biotherapeutics Inc based on Relative Valuation is -980.0%.
The range of the Relative Valuation is (15.13) - (21.38) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.5x - 19.0x | 13.7x |
| Forward P/E multiples | 12.9x - 21.3x | 13.7x |
| Fair Price | (15.13) - (21.38) | (15.40) |
| Upside | -964.6% - -1321.7% | -980.0% |
| Date | P/E |
| 2025-07-01 | -1.55 |
| 2025-06-30 | -1.53 |
| 2025-06-27 | -1.50 |
| 2025-06-26 | -1.55 |
| 2025-06-25 | -1.58 |
| 2025-06-24 | -1.67 |
| 2025-06-23 | -1.65 |
| 2025-06-20 | -1.76 |
| 2025-06-18 | -1.81 |
| 2025-06-17 | -1.80 |
| 2025-06-16 | -1.85 |
| 2025-06-13 | -1.99 |
| 2025-06-12 | -2.06 |
| 2025-06-11 | -1.99 |
| 2025-06-10 | -2.12 |
| 2025-06-09 | -1.97 |
| 2025-06-06 | -1.82 |
| 2025-06-05 | -1.60 |
| 2025-06-04 | -1.63 |
| 2025-06-03 | -1.62 |
| 2025-06-02 | -1.57 |
| 2025-05-30 | -1.56 |
| 2025-05-29 | -1.63 |
| 2025-05-28 | -1.56 |
| 2025-05-27 | -1.54 |
| 2025-05-23 | -1.58 |
| 2025-05-22 | -1.56 |
| 2025-05-21 | -1.56 |
| 2025-05-20 | -1.70 |
| 2025-05-19 | -1.63 |
| 2025-05-16 | -1.48 |
| 2025-05-15 | -1.57 |
| 2025-05-14 | -1.52 |
| 2025-05-13 | -1.59 |
| 2025-05-12 | -1.72 |
| 2025-05-09 | -1.56 |
| 2025-05-08 | -2.82 |
| 2025-05-07 | -2.78 |
| 2025-05-06 | -2.76 |
| 2025-05-05 | -3.11 |
| 2025-05-02 | -3.11 |
| 2025-05-01 | -2.96 |
| 2025-04-30 | -3.19 |
| 2025-04-29 | -3.17 |
| 2025-04-28 | -3.21 |
| 2025-04-25 | -3.12 |
| 2025-04-24 | -2.99 |
| 2025-04-23 | -2.84 |
| 2025-04-22 | -2.86 |
| 2025-04-21 | -2.74 |